By indication / Pan-cancer / multiple tumour types

Pan-cancer / multiple tumour types

17 imaging agents and 14 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.

Imaging

AgentIsotopeStageRuns
[68Ga]Ga-FAPI-46
paired with [177Lu]Lu-FAPI-46
Ga-68Clinical research41
[18F]FDGF-18Approved40
[18F]FSPGF-18Clinical research7
[68Ga]Ga-FAPI-04
paired with [177Lu]Lu-FAPI-04
Ga-68—6
[18F]FTYRF-18Research3
[68Ga]Ga-OncoFAP-DOTAGAGa-68Research2
[18F]FAPI-74F-18—2
[18F]fluoroacetateF-18—2
[68Ga]DOTA-A1-HisGa-68Preclinical2
[11C]CP31398C-11Preclinical1
10-[11C]methoxy-20(S)-camptothecinC-11Preclinical1
[11C]YM155C-11—1
[89Zr]PEG-Nb159Zr-89Reported once1
[68Ga]DOTA-FD1
paired with [177Lu]Lu-DOTA-FD1
Ga-68Reported once1
[18F]AlF-OncoFAPF-18—
[18F]L-GlutamicF-18Clinical research
[68Ga]Ga-OncoFAP
paired with [177Lu]Lu-OncoFAP
Ga-68Clinical research

Therapy

AgentIsotopeStageRuns
[188Re]Re-188-DTPA-deoxyglucoseRe-188—2
[177Lu]Lu-AKIR001Lu-177Clinical research2
[177Lu]Lu-LuCl3Lu-177—1
[177Lu]Lu-NeoBLu-177Clinical research1
[225Ac]Ac-DOTA-hu3F8Ac-225Preclinical1
[90Y]Y-90-FF-21101Y-90Clinical research1
[131I]MAANI-131Preclinical1
[177Lu]Lu-DOTA-TRK-950Lu-177Preclinical1
[177Lu]Lu-DOTA-MI-exendin-4Lu-177Reported once1
[131I]MEGMIB-5F7GGCI-131Reported once1
[90Y]Y-pentixatherY-90—
[177Lu]Lu-OncoFAP
paired with [68Ga]Ga-OncoFAP
Lu-177Preclinical
[211At]At-211-AMT
paired with [11C]AMT
At-211Preclinical
2-[211At]astato-α-methyl-L-phenylalanineAt-211Preclinical

Other entries

AgentIsotopeStageRuns
[68Ga]Ga-DATA5m.SA.FAPiGa-68Clinical research1
[68Ga]Ga-TrivehexinGa-68Clinical research1
[18F]TalazoparibF-18Preclinical1
[177Lu]Lu-[Nle15]MG11Lu-177—
[131I]I-ferulic acidI-131—
[111In]In-bleomycinIn-111—

Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.

Get in touch
Ask a question